Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
|---|---|
| Enthalten in: |
International journal of hematology - 107(2018), 6 vom: 18. Juni, Seite 717-719 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hosoi, Hiroki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 31.10.2018 Date Revised 14.11.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12185-018-2456-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM283193735 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM283193735 | ||
| 003 | DE-627 | ||
| 005 | 20231225035932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12185-018-2456-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0943.xml |
| 035 | |a (DE-627)NLM283193735 | ||
| 035 | |a (NLM)29671245 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hosoi, Hiroki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.10.2018 | ||
| 500 | |a Date Revised 14.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a mogamulizumab |2 NLM | |
| 650 | 7 | |a YI437801BE |2 NLM | |
| 700 | 1 | |a Mushino, Toshiki |e verfasserin |4 aut | |
| 700 | 1 | |a Nishikawa, Akinori |e verfasserin |4 aut | |
| 700 | 1 | |a Hashimoto, Hisako |e verfasserin |4 aut | |
| 700 | 1 | |a Murata, Shogo |e verfasserin |4 aut | |
| 700 | 1 | |a Hatanaka, Kazuo |e verfasserin |4 aut | |
| 700 | 1 | |a Tamura, Shinobu |e verfasserin |4 aut | |
| 700 | 1 | |a Hanaoka, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Norio |e verfasserin |4 aut | |
| 700 | 1 | |a Sonoki, Takashi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of hematology |d 1997 |g 107(2018), 6 vom: 18. Juni, Seite 717-719 |w (DE-627)NLM012627607 |x 1865-3774 |7 nnns |
| 773 | 1 | 8 | |g volume:107 |g year:2018 |g number:6 |g day:18 |g month:06 |g pages:717-719 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12185-018-2456-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 107 |j 2018 |e 6 |b 18 |c 06 |h 717-719 | ||